Related Experiment Video
Updated: May 21, 2025

Author Spotlight: Exploring the Role of Unfolded Protein Response in HIV-1 Replication and Infectivity
Published on: June 14, 2024
Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus
Meilynn Shi1, Matthew J Feinstein1
1Division of Cardiology, Department of Medicine, Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Insights
People with human immunodeficiency virus (HIV) face higher risks of ischemic heart disease due to various factors. Understanding inflammation mechanisms is key for better prevention, diagnostics, and treatments for cardiovascular issues in HIV patients.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Immunology
Background:
- Individuals with human immunodeficiency virus (HIV) have increased risks for ischemic heart disease and cardiovascular complications.
- Contributing factors include traditional comorbidities, antiretroviral therapy side effects, persistent viral activity, co-infections, mucosal damage, and chronic immune system imbalance.
Purpose of the Study:
- To review current knowledge on cardiovascular risks in HIV patients.
- To explore the role of inflammation in HIV-associated cardiovascular disease.
- To discuss clinical phenotypes, diagnostics, and potential treatments.
Main Methods:
- Literature review of foundational and recent studies.
- Analysis of clinical data and research on inflammatory pathways.
- Examination of diagnostic tools and pharmacotherapies.
Main Results:
- HIV infection is linked to a complex interplay of factors exacerbating cardiovascular risk.
- Inflammation and immune dysregulation are central mechanisms driving these risks.
- Current research identifies various clinical presentations and therapeutic targets.
Conclusions:
- A comprehensive understanding of HIV-related cardiovascular disease mechanisms, particularly inflammation, is crucial.
- This knowledge can guide the development of improved prevention, diagnostic, and therapeutic strategies.
- Further translational research is needed for clinical implementation to improve patient outcomes.
Abstract:
Individuals with human immunodeficiency virus (HIV) experience an elevated risk of ischemic heart disease and related cardiovascular sequelae. This is due to a combination of factors including traditional comorbidities, adverse effects of antiretroviral therapy, low-level viremia, viral coinfection, mucosal injury, and chronic immune activation and dysregulation. Understanding the underlying mechanisms, especially as they relate to inflammation, has implications for prevention, diagnostics, and therapeutics. This review highlights some of the foundational and recent literature on clinical phenotypes, diagnostic tools, and promising pharmacotherapies, along with future directions for translational research and clinical implementation.
More Related Videos
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Sexually Transmitted Infections
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pathophysiology of Heart Failure

